市場調査レポート
商品コード
1617408

経皮ドラッグデリバリーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2024年版)

Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


出版日
発行
GlobalData
ページ情報
英文 431 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経皮ドラッグデリバリーのパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業(2024年版)
出版日: 2024年12月10日
発行: GlobalData
ページ情報: 英文 431 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、経皮ドラッグデリバリーのパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

  • 経皮ドラッグデリバリーの概要

第3章 開発中の製品

  • 経皮ドラッグデリバリー - パイプライン製品:開発段階別
  • 経皮ドラッグデリバリー - パイプライン製品:セグメント別
  • 経皮ドラッグデリバリー - パイプライン製品:地域別
  • 経皮ドラッグデリバリー - パイプライン製品:規制経路別
  • 経皮ドラッグデリバリー - パイプライン製品:推定承認日別
  • 経皮ドラッグデリバリー - 進行中の臨床試験

第4章 経皮ドラッグデリバリー - 各社の開発中のパイプライン製品

  • 経皮ドラッグデリバリー企業 - パイプライン製品:開発段階別
  • 経皮ドラッグデリバリー - パイプライン製品:開発段階別

第5章 経皮ドラッグデリバリーの企業と製品の概要

第6章 経皮ドラッグデリバリー - 近年の発展

第7章 付録

図表

List of Tables

  • Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Transdermal Drug Delivery - Pipeline Products by Segment
  • Transdermal Drug Delivery - Pipeline Products by Territory
  • Transdermal Drug Delivery - Pipeline Products by Regulatory Path
  • Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transdermal Drug Delivery - Ongoing Clinical Trials
  • Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
  • Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Glossary

List of Figures

  • Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • Transdermal Drug Delivery - Pipeline Products by Segment
  • Transdermal Drug Delivery - Pipeline Products by Territory
  • Transdermal Drug Delivery - Pipeline Products by Regulatory Path
  • Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Transdermal Drug Delivery - Ongoing Clinical Trials
目次
Product Code: GDME1898EPD

GlobalData's Medical Devices sector report, "Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Transdermal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transdermal Drug Delivery Devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transdermal Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transdermal Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transdermal Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transdermal Drug Delivery Overview

3 Products under Development

  • 3.1 Transdermal Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Transdermal Drug Delivery - Pipeline Products by Segment
  • 3.3 Transdermal Drug Delivery - Pipeline Products by Territory
  • 3.4 Transdermal Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Transdermal Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Transdermal Drug Delivery - Ongoing Clinical Trials

4 Transdermal Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Transdermal Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Transdermal Drug Delivery - Pipeline Products by Stage of Development

5 Transdermal Drug Delivery Companies and Product Overview

6 Transdermal Drug Delivery- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer